Autopsy report · NCT06315842
Levels of Diagnostic and Therapeutic Intervention in Hospitalized Patients
Cause of deathStaffing, sites or logistics
“Feasibility issues (organizational changes required to perform the trial are not feasible)”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Na
- Sponsor
- Consorci Sanitari de l'Alt Penedès i Garraf
- Sponsor type
- University, hospital or other
- Conditions
- Acute Disease
- Interventions
- Levels of Diagnostic and Therapeutic Intervention tool by Fontecha and col.; Usual clinical practice
- Participants
- 0
- Sites
- 1
- Countries
- Spain
Trials that died the same way
- Compare Technegas Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging for Pulmonary Embolism
“Decision to change trial design.” - Regorafenib-pembrolizumab vs. TACE/TARE in Intermediate Stage HCC Beyond Up-to-7
“The trial ended earlier than planned due to slow enrolment, which has made it unfeasible to achieve the target sample size within a reasonable timeframe. Consequently, a business decision has been made to discontinue funding for the trial.” - Gabapentin and Oxcarbazepine for Chronic Neuropathic Pain in Children and Adolescents: A Clinical Effectiveness Study
“Study was withdrawn for feasibility-related concerns.” - Point of Care Ultrasound in Obstetric Triage
“Feasibility issue at institution” - Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)
“Company decision to discontinue trial”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.